NEW YORK, Feb. 18, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LogicBio Therapeutics, Inc. ("LogicBio" or the "Company") (NASDAQ: LOGC). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext....
from PR Newswire: https://ift.tt/2SD6xDe
No comments:
Post a Comment